Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Good adherence and early efficacy using desonide hydrogel for atopic dermatitis: results from a program addressing patient compliance.

Yentzer BA, Camacho FT, Young T, Fountain JM, Clark AR, Feldman SR.

J Drugs Dermatol. 2010 Apr;9(4):324-9.

PMID:
20514788
2.

Effect of desonide hydrogel 0.05% on the hypothalamic-pituitary-adrenal axis in pediatric subjects with moderate to severe atopic dermatitis.

Eichenfield LF, Basu S, Calvarese B, Trancik RJ.

Pediatr Dermatol. 2007 May-Jun;24(3):289-95.

PMID:
17542883
3.
4.

Multicenter trial for long-term safety and efficacy comparison of 0.05% desonide and 1% hydrocortisone ointments in the treatment of atopic dermatitis in pediatric patients.

Jorizzo J, Levy M, Lucky A, Shavin J, Goldberg G, Dunlap F, Hinds A, Strelka L, Baker M, Tuley M, et al.

J Am Acad Dermatol. 1995 Jul;33(1):74-7.

PMID:
7601950
5.

Safety and efficacy of desonide hydrogel 0.05% in pediatric subjects with atopic dermatitis.

Hebert AA, Cook-Bolden FE, Basu S, Calvarese B, Trancik RJ; Desonide Hydrogel Study Group.

J Drugs Dermatol. 2007 Feb;6(2):175-81.

PMID:
17373176
6.

Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopic dermatitis.

Krejci-Manwaring J, Tusa MG, Carroll C, Camacho F, Kaur M, Carr D, Fleischer AB Jr, Balkrishnan R, Feldman SR.

J Am Acad Dermatol. 2007 Feb;56(2):211-6. Epub 2006 Nov 13.

PMID:
17224366
7.

The importance of vehicle properties to patients with atopic dermatitis.

Trookman NS, Rizer RL, Ho ET, Ford RO, Gotz V.

Cutis. 2011 Jul;88(1 Suppl):13-7.

PMID:
21919229
8.

A novel hydrogel vehicle formulated for the treatment of atopic dermatitis.

Kircik L, Del Rosso J.

J Drugs Dermatol. 2007 Jul;6(7):718-22. Review.

PMID:
17763596
9.

Safety, efficacy, and dosage of 1% pimecrolimus cream for the treatment of atopic dermatitis in daily practice.

Lübbe J, Friedlander SF, Cribier B, Morren MA, García-Díez A, Gelmetti C, Hofmann H, Houwing RH, Kownacki S, Langley RG, Virtanen M, Wolff K, Wisseh S, McGeown C, Abrams B, Schneider D; NOBEL (New Online Based ELidel) Study Group.

Am J Clin Dermatol. 2006;7(2):121-31.

PMID:
16605292
10.

The effect of desonide hydrogel on pruritis associated with atopic dermatitis.

Kircik L.

J Drugs Dermatol. 2014 Jun;13(6):725-8.

PMID:
24918564
11.

A multicenter trial of the efficacy and safety of 0.03% tacrolimus ointment for atopic dermatitis in Korea.

Won CH, Seo PG, Park YM, Yang JM, Lee KH, Sung KJ, Park CW, Kim DW, Chang HS, Won YH, Kim KH.

J Dermatolog Treat. 2004 Jan;15(1):30-4.

PMID:
14754647
12.

A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.

Ling M, Gottlieb A, Pariser D, Caro I, Stewart D, Scott G, Abrams K.

J Dermatolog Treat. 2005 Aug;16(3):142-8.

PMID:
16096179
13.
14.
15.

Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients.

Hanifin J, Gupta AK, Rajagopalan R.

Br J Dermatol. 2002 Sep;147(3):528-37.

PMID:
12207596
16.

Improvement in treatment adherence with a 3-day course of fluocinonide cream 0.1% for atopic dermatitis.

Yentzer BA, Ade RA, Fountain JM, Clark AR, Taylor SL, Borgerding E, Feldman SR.

Cutis. 2010 Oct;86(4):208-13.

PMID:
21140931
17.

Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study.

Schachner LA, Lamerson C, Sheehan MP, Boguniewicz M, Mosser J, Raimer S, Shull T, Jaracz E; US Tacrolimus Ointment Study Group.

Pediatrics. 2005 Sep;116(3):e334-42.

PMID:
16140675
18.

Moisturizing advantages of desonide hydrogel in treating atopic dermatitis.

Trookman NS, Rizer RL, Ho ET, Ford RO, Gotz V.

Cutis. 2011 Jul;88(1 Suppl):7-12.

PMID:
21916151
19.

Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.

Kubota Y, Yoneda K, Nakai K, Katsuura J, Moriue T, Matsuoka Y, Miyamoto I, Ohya Y.

J Am Acad Dermatol. 2009 Feb;60(2):212-7. doi: 10.1016/j.jaad.2008.09.034. Epub 2008 Nov 22.

PMID:
19027990
20.

Efficacy and safety of tacrolimus ointment in pediatric Patients with moderate to severe atopic dermatitis.

Singalavanija S, Noppakun N, Limpongsanuruk W, Wisuthsarewong W, Aunhachoke K, Chunharas A, Wananukul S, Akaraphanth R.

J Med Assoc Thai. 2006 Nov;89(11):1915-22.

PMID:
17205874

Supplemental Content

Support Center